About the Report
The global hyperthermia cancer treatment market is expected to expand at a healthy CAGR of approximately 6% over the 2031 to 2031 assessment period. Most of the revenue will be contributed by the sale of microwave hyperthermia cancer treatment devices.
Cancer treatment around the world is experiencing a paradigm shift, with healthcare providers opting for various non-invasive diagnostic and therapeutic approaches so as to minimize patient discomfort and improve clinical outcomes. This has boded well for the hyperthermia cancer treatment providers.Treatment for breast and prostate cancers are anticipated to generate maximum revenue pools, owing to their high prevalence rates. Furthermore, microwave hyperthermia cancer devices shall experience a major upswing.
In its new study, consulting firm Fact.MR offers insights about key factors driving demand for hyperthermia cancer treatment. The report tracks the global sales of the hyperthermia cancer treatment market in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the healthcare domain in general, and demand for hyperthermia treatment for cancer in particular.
How Do Historical and Future Projections Compare?
The market experienced credible growth in the historical period, largely driven by extensive applications in breast cancer treatment. Various technologies, including high intensity focused ultrasound (HIFU) and deep tissue & regional perfusion, have been deployed to eradicate this disease.
The market remain largely consistent throughout the COVID-19 pandemic, as cancer patients acquired top priority amid feared complications and casualties induced by possible infection. According to Fact.MR, the market is slated to reach over US$ 250 million by 2031, expanding at a healthy CAGR of nearly 6%.
Know More Details About the Report
How is Rising Cancer Burden Catalyzing Demand for Hyperthermia Treatment for Cancer?
Rise in prevalence and incidence of cancers such as breast, liver, soft tissue sarcoma, head & neck tumors, prostate cancer, and others drives demand for hyperthermia cancer treatment. According to the National Cancer Institute (NCI), an estimated 1.8 million cases are expected to be diagnosed in the U.S. in 2020, with prostate, lung, and colorectal cancer comprising 43% of the total cancer cases in men.
More than 60% of the world’s new cancer cases occur in Africa, Asia, and Central and South America, and 70% of the total cancer deaths globally occur in these regions. Most of these cancers impact the geriatrics, with around two out of five cases occurring amongst adults above 60 years of age.
Why is There Increased Preference for High Intensity Focused Ultrasound (HIFU)?
Therapeutic applications of heat is highly effective in cancer treatment. Hence companies are augmenting production capacities in high quality heating equipment to enable precise thermal dosimetry. This has generated innovations in antennas and power delivery systems that provide adequate quality assurance for the treatment of cancer patients.
High intensity focused ultrasound (HIFU), nanoparticle heating, and scanned focused ultrasound (SFUS) techniques are broadening revenue streams for companies involved in hyperthermia cancer treatment. As such, ultrasound hyperthermia devices are predicted to dominate the second highest revenue among all device types in the market.
Avail customized purchase options for your needs
Why is the U.S. a Highly Promising Market for Hyperthermia Cancer Treatment?
According to the National Cancer Institute, the rate of new cancers is 442.4 per 100,000 men and women per year, with mortality estimated at 158.3 per 100,000 men and women annually. Approximately, 39.5% of patients will be diagnosed with cancer at some point of their lives. The number of survivors is likely to reach 22.2 million by 2030.
Consequently, healthcare providers are seeking to integrate advanced treatment options, which is widening the scope for hyperthermia cancer treatment. The treatment is administered by the Pyrexar-500 that delivers heat energy directly into the cancerous tumor at temperatures between 104-113 degrees Fahrenheit which destroys malignant tumor cells, while minimizing damage to surrounding healthy tissue.
Do Prospects for Hyperthermia Cancer Treatment Solution Providers Look Good in the U.K.?
In recent years, medical practitioners have been tilting towards non-invasive cancer treatment approaches, a trend which has generated immense opportunities for hyperthermia treatment.
Prominent player Breakspear Medical is the first facility to offer hyperthermia cancer treatment. Its IRATHERM® 1000 whole-body hyperthermia bed not only raises body surface temperature, but also the core temperature which can have a major therapeutic effect. Besides cancer treatment, it is also useful for a host of other ailments, including arterial hypertension and rheumatic diseases.
Why are Sales of Microwave Devices Picking Up Pace?
Microwave hyperthermia cancer treatment devices shall capture an attractive revenue share, attributed to its ability to transmit energy from antenna to cancer cells without being impeded in fat layers. It is expected to yield over two-fifths of the revenue through 2031.
Simultaneously, ultrasound devices are expected to garner significant momentum, owing to its non-invasive nature. Several manufacturers are augmenting their operations to include more ultrasound devices.
How is Breast Cancer Treatment Stimulating Overall Market Growth?
Globally, breast cancer is the most prevalent type of cancer, affecting over 2 million women as of 2018. Moreover, it is the most prevalent cancer type across the world. Hence, key manufacturers are developing highly advanced hyperthermic treatment approaches to cure this deadly disease.
PYREXAR Medical is a pioneer in this regard, offering the BSD-500 portable superficial hyperthermia treatment device designed for palliative treatment of certain tumors, including breast cancer.
An Adaptive Approach to Modern-day Research Needs
Introducing technologically advanced products and strengthening distribution networks form the core expansion strategy of prominent market players. Some notable developments are as follows:
- In February 2021, innoMedicus Ltd. published a study in JAMA Oncology, establishing that non-contrast MRI yields better diagnosis of prostate cancer
- Likewise, Gamida Cell announced a US$ 75 million financing with Highbridge Capital Management to further its Omidubicel and GDA-201 clinical development
*This list is indicative-full details about key players are available upon request.
Historical Data Available for
US$ Mn for Value & ‘000 Units for Volume
Key Regions Covered
Key Countries Covered
Key Segments Covered
Key Companies Profiled
Customization & Pricing
Key Market Segments Covered
- Infrared Devices for Hyperthermia Cancer Treatment
- Magnetic Hyperthermia Devices
- Ultrasound Hyperthermia Devices
- Microwave Devicesfor Hyperthermia Cancer Treatment
- Loco-regional Method
- External & Interstitial
- Intraluminal or Endocavitary Methods
- Continuous Hyperthermic Peritoneal Perfusion (CHPP)
- Deep Tissue & Regional Perfusion
- Whole Body
- Breast Cancer
- Liver Cancer
- Soft Tissue Sarcoma
- Head & Neck Tumors
- Prostate Cancer
- for Hyperthermia Cancer Treatment at Hospitals & Specialty Clinics
- for Hyperthermia Cancer Treatment at Ambulatory Surgical Centers
- North America
- Rest of Europe
- Australia & New Zealand
- Rest of APAC
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of MEA
- North America
Hyperthermia Cancer Treatment Market - Scope of Report
A recent study by Fact.MR on the hyperthermia cancer treatment market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering hyperthermia cancer treatment.
The study also provides the dynamics that are responsible for influencing the future status of the hyperthermia cancer treatment market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.
A list of prominent companies operating in the hyperthermia cancer treatment space, along with their product portfolios, enhances the reliability of this comprehensive research study.
The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of hyperthermia cancer treatment solutions across the globe.
A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of hyperthermia cancer treatment solutions during the forecast period. Price point comparison by region with global average price is also considered in the study.
Key Questions Answered in Report
- Which are the most lucrative markets for hyperthermia cancer treatment?
- Which factors will impact the growth of the market over the coming years?
- How will changing trends impact the strategies of market players?
- How can market players capture the low-hanging opportunities across regions?
- Which companies are leading the hyperthermia cancer treatment industry?
- What are the winning strategies of stakeholders in the market?
Analysis on Market Size Evaluation
The market has been analyzed for each market segment in terms of volume (‘000 Units) and value (US$ Mn).
Market estimates at global and regional levels for hyperthermia cancer treatment are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global hyperthermia cancer treatment market.
Inspected Assessment on Regional Segments
Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.
Country-specific valuation on demand for hyperthermia cancer treatment has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value and volume for emerging countries has also been included in the report.
In-depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of hyperthermia cancer treatment solutions, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering hyperthermia cancer treatment solutions has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the hyperthermia cancer treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the research report as a primary resource.
- FAQ's -
Hyperthermia cancer treatment market is poised to surpass US$ 250 million in revenue by 2031, registering a healthy 6% CAGR throughout the forecast period
PYREXAR Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.r.l., Yamamoto Vinita Co. Ltd, Chongqing Haifu Medical Technology Co. Ltd., innoMedicus Ltd. and Gamida-Cell Ltd. and RanD are some prominent hyperthermia device manufacturers
The North American market is slated to accrue significant gains with regard to hyperthermia cancer treatment amid the ever swelling incidence of various types of cancers amongst all sections of the population
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report on the radiation proctitis treatment industry has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.